DRMA Dermata Therapeutics, Inc.
Healthcare$1.23-2.38%ClosedMarket Cap: $838,315
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.76
P/S
0.00
EV/EBITDA
0.83
DCF Value
$7.66
FCF Yield
-966.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-127.9%
ROA
-95.1%
ROIC
-114.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-1.9M | $-1.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-1.9M | $-1.9M | $— | — |
| FY null | $0.00 | NaN% | $-7.8M | $-7.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.8M | $-1.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-1.8M | $-1.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.3M | $-2.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.2M | $-3.2M | $— | — |
| FY null | $0.00 | NaN% | $-12.5M | $-12.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.2M | $-3.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.9M | $-2.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.2M | $-3.1M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-2.2M | $-2.1M | $-5.40 | — |